Please Note: This trial is no longer enrolling new participants
Phase II Trial to Investigate the Safety and Efficacy of Three Dosing Regimens of OTL78 Injection (Zopocianine), a Prostate-Specific Membrane Antigen (PSMA)-targeted Fluorescent Agent, for the Intraoperative Imaging of Prostate Cancer
| Protocol No. | UROL-CC-IUSCCC-0902 | Scope | Local |
|---|---|---|---|
| Principal Investigator | Clint Bahler | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase II |
